NexEos Diagnostics, Inc.

640 Lee Rd.

Suite 115
Wayne, PA 19087

USA

© 2019-2020 Copyright NexEos Diagnostics. All rights reserved.

NexEos Diagnostics, Inc. was founded with a mission of developing novel technologies to identify underlying inflammation in eosinophil-mediated diseases.
 
We bring a sense of urgency to all we do, knowing patients need better solutions to manage their debilitating diseases.
Illuminating eosinophil-driven inflammation for a brighter tomorrow.

Our lead program (NDX33-o) is a novel, non-invasive imaging agent for the diagnosis, treatment monitoring, and management of Eosinophilic Esophagitis (EoE).

We are passionate about our goal of helping patients to maintain a high quality of life and to slow the progression of eosinophil-related diseases.